arrow
W

Wencke Walter

mll munich leukemia laboratory
H指数:23
被引数:4,072

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Two cases of an imatinib-sensitive PRKG2::PDGFRA-positive chronic myeloid neoplasm with basophilia

两例对伊马替尼敏感的PRKG2::PDGFRA阳性伴嗜碱性粒细胞增多慢性髓系肿瘤

Leukemia
IF13.4
2026-09-280
OAAI
The machine-learning classifier ALLCatchR2 identifies 20 T-ALL subtypes across cohorts and age groups

机器学习分类器ALLCatchR2识别跨队列和年龄组的20种T-ALL亚型

2026-09-150
OAAI
Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms

Csnk1a1 E98突变重编程del(5q)骨髓增生异常性肿瘤的信号传导和代谢

Leukemia
IF13.4
2026-09-030
OA
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL

IntegrateALL:一种用于多层级数据提取和可解释亚型分类的B-前体ALL端到端RNA-seq分析流程

2026-04-160
OAAI
Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups

亚型内异质性塑造了KMT2A重排ALL在所有年龄组的治疗反应

2026-02-190
OAAI
A tumor-selective mRNA system enables precision cancer treatment

一种肿瘤选择性mRNA系统能够实现精准癌症治疗

2025-11-150
PRE
The RNA N6-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling

RNA N6-甲基腺苷甲基化组通过激活PI3K信号通路,协调长链非编码RNA以介导癌症耐药性。

2025-11-070
OAAI
Telomere content and genomics of myeloid neoplasia by WGS

端粒含量和髓系肿瘤的全基因组测序(WGS)基因组学

Blood
IF23.1
2025-09-240
OA
TELOMERE CONTENT IN MYELOID NEOPLASIA COULD INFORM ON DIFFERENTIAL SENSITIVITY TO TELOMERASE INHIBITORS

髓系肿瘤中的端粒含量可能提示对端粒酶抑制剂的差异性敏感性

2025-09-010
PRE
Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases

鲁索利替尼介导的矛盾性JAK2过度磷酸化是由于保护了激活环酪氨酸免受磷酸酶的影响。

LEUKEMIA
IF13.4
2025-04-230
OA
C/EBP Family Member Gene Fusions and Cooperating Genomic Events Define Two Distinct Molecular Sub-Groups in Adult B Precursor ALL

C/EBP家族成员基因融合及协同基因组事件定义了成人B细胞前体急性淋巴细胞白血病中的两个不同分子亚组

BLOOD
IF23.1
2024-11-050
PRE